510(k) Report

510(k) · Cleared

Cleared

System 2100

K993530510(k) TraditionalCleared Dec 15, 199958-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Math Solutions, LLC · LLZ System, Image Processing, Radiological

Cleared on Dec 15, 1999 after a 58-day review. The FDA summary names its predicate without a number.

Decided
Dec 15, 1999
Review
58 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
0

The FDA summary names its predicate without a number.

FIG. 1 — Lineage of K993530Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Precision View
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

The system is intended for use by any health practitioner who has the need for any of the below functions: 1. The software may be used to display medical images. The user may adjust the contrast of the images and image process the images with an edge enhancement algorithm. The user can zoom in on a region of an image, enlarging that region on the display screen. Other image processing functions may be added in the future to allow the user to enhance some…

Read the full statement (428 words)

The system is intended for use by any health practitioner who has the need for any of the below functions:

1. The software may be used to display medical images. The user may adjust the contrast of the images and image process the images with an edge enhancement algorithm. The user can zoom in on a region of an image, enlarging that region on the display screen. Other image processing functions may be added in the future to allow the user to enhance some aspect of an image, such as histogram processing, spatial filtering, frequency filtering.

2. Images from the same series can be stacked to form a three dimensional model. This will allow the use of the system to reformat images in other planes, such as coronal and sagittal planes.

3. Outlining tools are provided to use the system to outline regions of interest. These outlines may be combined to define three dimensional shapes which can be viewed in three dimensional perspective views.

4. The region of interest outlines may be written back to DICOM formatted image files for export to other systems.

5. The system can be used to determine the stereotactic coordinates of a point located on an image when a stereotactic system is employed.

6. The system may be used to provide support for any stereotactic system that consists of fixed rods which can be uniquely located on CT and MRI images.

7. The system may be used to solve for the transformation between two images sets, referred to as image fusion.

8. A region of interested outlined on one image set may be transferred to a fused image set.

9. The system may be used as a front end to other systems that do not provide image fusion. An example would be outlining a region of interest on MRI scans, transferring the outlines to CT scans, and writing the outlines back into DICOM image files. Those files can be available to other systems such as a radiation therapy treatment planning system.

10. The system may be used to print hardcopy images of selected images, reformatted images, and three dimensional perspective views.

11. Image segmentation tools are provided to create three dimensional structures for viewing in three dimensional perspective views.

The intention is also to provide these basic functions as a C++ object library to any party that may wish to use the library to build their own applications. Those customers will be completely responsible for the integration, testing, use of the end product that they produce, and compliance with federal and state regulations.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K993530: System 2100.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K993530

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026